Week Ending May 23, 2022

Role of Molecular Biology, Evolving Immunotherapy Addressed in Lung Cancer Conference
”At the upcoming 23rd Annual International Lung Cancer Congress®, Solange Peters, MD, PhD will be giving two presentation around relevant biomarkers in perioperative immunotherapy and the role of treatment agent sequencing in ALK-rearranged non–small cell lung cancer.”

Imaging Approach Helps To Detect Lung Cancer Earlier
“Researchers at the Abramson Cancer Center at the University of Pennsylvania  have found a way to identify lung cancer at the cellular level in real time during a biopsy, offering promise in the ability to detect the disease earlier and with more confidence.”

Medicaid expansion linked to survival gain, reduced disparities among patients with cancer
“The expansion of Medicaid under the Affordable Care Act correlated with an increase in 2-year OS rates among patients newly diagnosed with cancer, according to study results published in JNCI: Journal of the National Cancer Institute.”

Study shows 1 in 5 former smokers may be overlooked for cessation counseling
“A new UC Davis study published in the Journal of General Internal Medicine shows some people may be overlooked for tobacco cessation counseling,  putting them at risk for lung cancer. The study attributes the finding to the way health care providers are asking some people about their current tobacco use.”

Oritinib Shows Promise in EGFR T790M+ NSCLC
“The third generation EGFR tyrosine kinase inhibitor (TKI) oritinib (SH-1028) demonstrated almost complete disease control in previously treated patients with EGFR T790M–mutant, locally advanced or metastatic non–small cell lung cancer (NSCLC).”

Follow-Up Often Delayed After High-Risk Findings on Lung Cancer Screening
FRIDAY, May 20, 2022 (HealthDay News) — “Nearly half of lung cancer screening exams with high-risk Lung-RADS findings result in delays in care, according to a study presented at the American Thoracic Society 2022 International Conference, held from May 13 to 18 in San Francisco.”

Lung cancer funding needed
“On behalf of the Lung Cancer Research Foundation, my late father, and my patients, I ask that you join me in urging Congress to support $60 million for the lung cancer research program within the Congressionally Directed Medical Research Program in the latest Defense Department appropriations bill.”

Blood-based biomarker can predict the benefit of immunotherapy to lung cancer patients
“A blood-based tumor biomarker can predict the benefit of immunotherapy to patients with non-small cell lung cancer, according to a study published in Nature Medicine.”

Heiden to receive award from cancer research group
“Brendan Heiden, MD, a surgical resident and cardiothoracic surgery research fellow at Washington University School of Medicine in St. Louis, will receive the Harborside Endowed Merit Award from Conquer Cancer, the foundation of the American Society of Clinical Oncology (ASCO).”

Unecritinib Shows Efficacy as ROS1-Directed Therapy in NSCLC
“Unecritinib (TTQ-B3101) monotherapy showed promising efficacy in the first line for patients with ROS1-positive non–small cell lung cancer (NSCLC). Shun Lu, MD, PhD, a professor at Shanghai Chest Hospital at Jiao Tong University and chief of Shanghai Lung Cancer Center in China, presented the findings at the European Lung Cancer Congress 2022.”